BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14494361)

  • 21. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetics of human cell lines. III. Incorporation of 5-bromo- and 5-iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity.
    DJORDJEVIC B; SZYBALSKI W
    J Exp Med; 1960 Sep; 112(3):509-31. PubMed ID: 13723177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of 5-iododeoxyuridine upon the growth of some transplantable rodent tumors.
    JAFFE JJ; PRUSOFF WH
    Cancer Res; 1960 Oct; 20():1383-8. PubMed ID: 13789159
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic infusion of tritiated thymidine into mice with tumors.
    MENDELSOHN ML
    Science; 1962 Jan; 135(3499):213-5. PubMed ID: 14472535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the mechanism of action of 5-iododeoxyuridine, an analog of thymidine.
    PRUSOFF WH
    Cancer Res; 1960 Jan; 20():92-5. PubMed ID: 14435162
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenosinetriphosphatase as the factor inhibiting the enzymic synthesis of diphosphopyridine nucleotides in the tissues of rats and mice with transplanted tumours.
    KARA J; SORM F
    Neoplasma; 1959; 6():225-35. PubMed ID: 14404459
    [No Abstract]   [Full Text] [Related]  

  • 27. Alteration of L cell growth by antibody-stimulated incorporation of radioactive nucleosides.
    Shearer WT; Philpott GW; Parker CW
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):303-9. PubMed ID: 1171516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INCORPORATION OF I-125-LABELED IODODEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF MURINE AND HUMAN TISSUES FOLLOWING THERAPEUTIC DOSES.
    CLIFTON KH; SZYBALSKI W; HEIDELBERGER C; GOLLIN FF; ANSFIELD FJ; VERMUND H
    Cancer Res; 1963 Dec; 23():1715-23. PubMed ID: 14082864
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidine.
    PRUSOFF WH; JAFFE JJ; GUNTHER H
    Biochem Pharmacol; 1960 May; 3():110-21. PubMed ID: 14435159
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: Antineoplastic effect of iodine-125-labelled iododeoxyuridine.
    Bloomer WD; Adelstein SJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):509-11. PubMed ID: 1080145
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acid-soluble nucleotides in the mammary gland of sheep].
    DENAMUR R; FAUCONNEAU G; GUNTZ G
    C R Hebd Seances Acad Sci; 1959 Apr; 248(17):2531-3. PubMed ID: 13652476
    [No Abstract]   [Full Text] [Related]  

  • 32. DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO: I. CELL PROLIFERATION AND DEATH AS MEASURED BY INCORPORATION AND ELIMINATION OF IODODEOXYURIDINE.
    HUGHES WL; COMMERFORD SL; GITLIN D; KRUEGER RC; SCHULTZE B; SHAH V; REILLY P
    Fed Proc; 1964; 23():640-8. PubMed ID: 14191970
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of the growth of mouse leukemia cells in culture by 5-iododeoxyuridine.
    MATHIAS AP; FISCHER GA; PRUSOFF WH
    Biochim Biophys Acta; 1959 Dec; 36():560-1. PubMed ID: 14422291
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of insulin on the phosphorus-32 mononucleotide labelling of the isolated rat diaphragm in the controlled absence of extracellular glucose.
    VOLFIN P; EBOUE D; CLAUSER H
    Nature; 1961 Oct; 192():166-8. PubMed ID: 13926579
    [No Abstract]   [Full Text] [Related]  

  • 35. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immunostimulation. II. Increased nucleoside incorporation, DNA synthesis, and cell growth in L cells treated with anti-L cell antibody.
    Shearer WT; Philpott GW; Parker CW
    Cell Immunol; 1975 Jun; 17(2):447-62. PubMed ID: 1125994
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the incorporation of radioactive phosphate into the nucleotides of desoxyribonucleic acid].
    LANGEN P; LISS E
    Biochem Z; 1961; 335():187-98. PubMed ID: 14462096
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of Clostridium difficile detection by monolayer and by inhibition of nucleoside uptake.
    Fuhr JE; Trent DJ; Collmann IR
    Am J Clin Pathol; 1987 Feb; 87(2):270-2. PubMed ID: 3544801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodine-123-iododeoxyuridine: a potential indicator of tumour response to treatment.
    Robins AB; Taylor DM
    Int J Nucl Med Biol; 1981; 8(1):53-63. PubMed ID: 7228519
    [No Abstract]   [Full Text] [Related]  

  • 40. Purine metabolism in mouse ascites tumor cells. III. In vivo incorporation of preformed purines into nucleotides and polynucleotides.
    WILLIAMS AM; LEPAGE GA
    Cancer Res; 1958 Jun; 18(5):562-8. PubMed ID: 13547050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.